Get started
ACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITED

ACTINOGEN MEDICAL LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ACW chart


Full chart

ACW upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪128.45 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.006 AUD
Net income (FY)
‪−13.04 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪2.64 B‬
Beta (1Y)
−1.03

About ACTINOGEN MEDICAL LIMITED


Sector
Health Technology
CEO
Steven G. Gourlay
Headquarters
Sydney
Website
actinogen.com.au
Founded
1999
ISIN
AU000000ACW3
FIGI
BBG000PS5K82
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ACW news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ACW is 0.041 AUD — it has increased by 10.81% in the past 24 hours. Watch ACTINOGEN MEDICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ACTINOGEN MEDICAL LIMITED stocks are traded under the ticker ACW.
ACW stock has risen by 5.13% compared to the previous week, the month change is a 57.69% rise, over the last year ACTINOGEN MEDICAL LIMITED has showed a 1.39% increase.
ACW reached its all-time high on Oct 16, 2007 with the price of 0.842 AUD, and its all-time low was 0.006 AUD and was reached on Sep 6, 2019. View more price dynamics on ACW chart.
See other stocks reaching their highest and lowest prices.
ACW stock is 16.67% volatile and has beta coefficient of −1.03. Track ACTINOGEN MEDICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is ACTINOGEN MEDICAL LIMITED there?
Today ACTINOGEN MEDICAL LIMITED has the market capitalization of ‪128.44 M‬, it has increased by 3.23% over the last week.
Yes, you can track ACTINOGEN MEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
ACTINOGEN MEDICAL LIMITED is going to release the next earnings report on Feb 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ACW net income for the last half-year is ‪−1.49 M‬ AUD, while the previous report showed ‪−11.56 M‬ AUD of net income which accounts for 87.13% change. Track more ACTINOGEN MEDICAL LIMITED financial stats to get the full picture.
No, ACW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTINOGEN MEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACTINOGEN MEDICAL LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACTINOGEN MEDICAL LIMITED stock shows the buy signal. See more of ACTINOGEN MEDICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.